% | $
Quotes you view appear here for quick access.

Neurocrine Biosciences Inc. Message Board

  • redshrimphunting redshrimphunting Sep 10, 2013 1:44 PM Flag

    Pipeline is packed....diversify is a good word in investing...

    "The bigger picture
    Neurocrine's stock got hit hard by this disappointing news. However, the results for the 100 mg dose at least give investors some hope that NBI-98854 could still achieve success.

    The even better news for Neurocrine, though, is that it isn't relying solely on the VMAT2 inhibitor. The company has two studies under way for elagolix with partner AbbVie (NYSE: ABBV )"

    Bump in the road, we should get back in track in the am. $13+ by friday.

53.94-0.22(-0.41%)Sep 23 4:00 PMEDT